The DNA Testing market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 81.82 billion in 2033, at a CAGR of 23.20%.

When we can play any part in supporting other families, it’s a tragic gift that allows us to continue to parent Havi.” For ...

Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its target price cut by analysts at Piper Sandler from $24.00 to $14.00 in a research note issued on Thursday,Benzinga reports. The brokerage ...

Consumer Genomics Market growth is driven by rapid advancements in genetic testing technologies, declining sequencing costs, and increasing consumer awarenessPune, Jan. 31, 2025 (GLOBE NEWSWIRE) -- ...

The gene panel market is expected to grow at 20.02 % CAGR from 2023 to 2030. It is expected to reach above USD 13.2 billion by 2030 from USD 3.02 billion in 2023. List of the Top Key Players of the ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

Piper Sandler analyst David Westenberg lowered the firm’s price target on Myriad Genetics (MYGN) to $14 from $24 and keeps a Neutral rating on ...

The rise of pastoralist peoples in the Eurasian steppes and their westward spread some 5,000 years ago may have been fueled by sheep herding and people exploiting their milk. As early as 8,000 years ...

By reducing the cost of breeding, the firm hopes to improve yields and other properties for an array of important crops ...

A surprisingly trend was that we saw genetic diversity declining even among” many species that aren’t considered at risk, ...